156 related articles for article (PubMed ID: 34233450)
1. The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy.
Homan CC; King-Smith SL; Lawrence DM; Arts P; Feng J; Andrews J; Armstrong M; Ha T; Dobbins J; Drazer MW; Yu K; Bödör C; Cantor A; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Fitzgibbon J; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Liu P; Godley LA; Schreiber AW; Hahn CN; Scott HS; Brown AL
Haematologica; 2021 Nov; 106(11):3004-3007. PubMed ID: 34233450
[No Abstract] [Full Text] [Related]
2. Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies.
Decker M; Lammens T; Ferster A; Erlacher M; Yoshimi A; Niemeyer CM; Ernst MPT; Raaijmakers MHGP; Duployez N; Flaum A; Steinemann D; Schlegelberger B; Illig T; Ripperger T
Leukemia; 2021 Nov; 35(11):3304-3308. PubMed ID: 33692461
[No Abstract] [Full Text] [Related]
3. Bone Marrow Morphology Associated With Germline
Chisholm KM; Denton C; Keel S; Geddis AE; Xu M; Appel BE; Cantor AB; Fleming MD; Shimamura A
Pediatr Dev Pathol; 2019; 22(4):315-328. PubMed ID: 30600763
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing familial platelet disorder with predisposition to myeloid malignancy: Lessons learned from a germline whole-gene deletion of RUNX1.
Cliburn JA; Uy JC; Swift S; Liesveld JL; Iqbal MA; Jajosky AN; Becker MW
Int J Lab Hematol; 2024 Feb; 46(1):203-206. PubMed ID: 37953439
[No Abstract] [Full Text] [Related]
5. Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome.
Jongmans MC; Kuiper RP; Carmichael CL; Wilkins EJ; Dors N; Carmagnac A; Schouten-van Meeteren AY; Li X; Stankovic M; Kamping E; Bengtsson H; Schoenmakers EF; van Kessel AG; Hoogerbrugge PM; Hahn CN; Brons PP; Scott HS; Hoogerbrugge N
Leukemia; 2010 Jan; 24(1):242-6. PubMed ID: 19946261
[No Abstract] [Full Text] [Related]
6. Acute myeloid leukemia in a child with familial platelet disorder and a cryptic
Dodson LM; Kurtz KJ; Marcogliese AN; Friend BD; Stevens AM; Fisher KE
Pediatr Hematol Oncol; 2022 Sep; 39(6):580-585. PubMed ID: 35135432
[No Abstract] [Full Text] [Related]
7. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.
Preudhomme C; Renneville A; Bourdon V; Philippe N; Roche-Lestienne C; Boissel N; Dhedin N; André JM; Cornillet-Lefebvre P; Baruchel A; Mozziconacci MJ; Sobol H
Blood; 2009 May; 113(22):5583-7. PubMed ID: 19357396
[TBL] [Abstract][Full Text] [Related]
8. Genetic basis of myeloid transformation in familial platelet disorder/acute myeloid leukemia patients with haploinsufficient RUNX1 allele.
Sakurai M; Kasahara H; Yoshida K; Yoshimi A; Kunimoto H; Watanabe N; Shiraishi Y; Chiba K; Tanaka H; Harada Y; Harada H; Kawakita T; Kurokawa M; Miyano S; Takahashi S; Ogawa S; Okamoto S; Nakajima H
Blood Cancer J; 2016 Feb; 6(2):e392. PubMed ID: 26849013
[No Abstract] [Full Text] [Related]
9. A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies.
Kirito K; Sakoe K; Shinoda D; Takiyama Y; Kaushansky K; Komatsu N
Haematologica; 2008 Jan; 93(1):155-6. PubMed ID: 18166807
[TBL] [Abstract][Full Text] [Related]
10. Gene of the issue: RUNX1 mutations and inherited bleeding.
Morgan NV; Daly ME
Platelets; 2017 Mar; 28(2):208-210. PubMed ID: 28277065
[No Abstract] [Full Text] [Related]
11. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
Schlegelberger B; Heller PG
Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
[TBL] [Abstract][Full Text] [Related]
12. [Allogeneic hematopoietic stem cell transplantation for Familial platelet disorder with a propensity for acute myeloid malignancies with Runx1 germline mutations: a case report and literature review].
Wang LL; Guan J; Cheng P; Zhang T; Cheng H; Zou L
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):517-520. PubMed ID: 35968597
[No Abstract] [Full Text] [Related]
13. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.
Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD
Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335
[TBL] [Abstract][Full Text] [Related]
14. C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies.
Staňo Kozubík K; Radová L; Pešová M; Réblová K; Trizuljak J; Plevová K; Fiamoli V; Gumulec J; Urbánková H; Szotkowski T; Mayer J; Pospíšilová Š; Doubek M
Int J Hematol; 2018 Dec; 108(6):652-657. PubMed ID: 30083851
[TBL] [Abstract][Full Text] [Related]
15. GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant.
Lamolda M; Montes R; Simón I; Perales S; Martínez-Navajas G; Lopez-Onieva L; Ríos-Pelegrina R; Del Moral RG; Griñan-Lison C; Marchal JA; Lozano ML; Ramos-Mejia V; Rivera J; Bastida JM; Real PJ
Stem Cell Res; 2019 Dec; 41():101603. PubMed ID: 31698193
[TBL] [Abstract][Full Text] [Related]
16. Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
Iizuka H; Kagoya Y; Kataoka K; Yoshimi A; Miyauchi M; Taoka K; Kumano K; Yamamoto T; Hotta A; Arai S; Kurokawa M
Exp Hematol; 2015 Oct; 43(10):849-57. PubMed ID: 26021490
[TBL] [Abstract][Full Text] [Related]
17. A novel RUNX1 exon 3 - 7 deletion causing a familial platelet disorder.
Almazni I; Chudakou P; Dawson-Meadows A; Downes K; Freson K; Mason J; Page P; Reay K; Myers B; Morgan NV;
Platelets; 2022 Feb; 33(2):320-323. PubMed ID: 33616470
[TBL] [Abstract][Full Text] [Related]
18. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia.
Glembotsky AC; Sliwa D; Bluteau D; Balayn N; Marin Oyarzún CP; Raimbault A; Bordas M; Droin N; Pirozhkova I; Washington V; Goette NP; Marta RF; Favier R; Raslova H; Heller PG
Haematologica; 2019 Jun; 104(6):1244-1255. PubMed ID: 30545930
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies.
Duarte BKL; Yamaguti-Hayakawa GG; Medina SS; Siqueira LH; Snetsinger B; Costa FF; Rauh MJ; Ozelo MC
Br J Haematol; 2019 Sep; 186(5):724-734. PubMed ID: 31124578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
